Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
XMMC Healthcare, an offshoot of the Xiamen Micro-Nano Manufacturing Center (XMMC), is a specialized Contract Development and Manufacturing Organization (CDMO) focused on microfluidic chips and biochip technologies. The company provides end-to-end services ranging from chip design and prototyping to large-scale GMP manufacturing for the life sciences and healthcare industries. Their technology platform supports a wide array of applications, including point-of-care testing (POCT), molecular diagnostics, and organ-on-a-chip systems. By leveraging advanced micro-nano fabrication techniques, XMMC Healthcare enables biotech and pharmaceutical partners to accelerate the development of high-precision diagnostic tools and research platforms. The company is a key player in the Chinese microfluidics ecosystem, serving both domestic and international clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on XMMC Healthcare.